Navigation Links
Light shines for potential early cancer diagnosis technique
Date:12/11/2008

A team led by a Northwestern University biomedical engineer has developed a new optical technique that holds promise for minimally invasive screening methods for the early diagnosis of cancer.

The researchers have shown for the first time that nanoscale changes are present in cells extremely early on in carcinogenesis. Their technique, partial-wave spectroscopy (PWS), can detect subtle abnormal changes in human colon cancer cells even when those same cells appear normal using conventional microscopy.

The study is published online by the Proceedings of the National Academy of Sciences.

A simple yet sensitive method, PWS quantifies the statistical properties of cell nanoscale architecture by using the signal generated by light waves striking the cell.

PWS can provide information not only about individual cells, but it also can look inside the cell and see the cell's fundamental "building blocks," such as proteins, nucleosomes and intracellular membranes, and detect changes to this cell nanoarchitecture. Conventional microscopy cannot do this, and other techniques that can (to some degree) are expensive and complex.

"Imagine a cell as a house and the cell's fundamental building blocks as bricks," said Vadim Backman, professor of biomedical engineering at Northwestern's McCormick School of Engineering and Applied Science.

"Our technique can see not only the sizes of the house's bricks but the details of those bricks. And it can show when those bricks are in trouble even when the house looks normal. Conventional microscopy can see the individual houses but not the bricks that make up the house. That's a significant difference," said Backman, who led the research.

Backman and his colleagues studied both human colon cancer cell lines and cells from a colon cancer animal model. In both cases, the PWS technique showed that an increase in the disorder of cells on the nanoscale parallels genetic events in the early stages of carcinogenesis.

"We have to look at cell morphology at the nanoscale," said Backman. "Cells are not just a bag of molecules -- the nanoarchitecture can control many cellular processes and activities."

The team studied three variants of malignant human cells, each exhibiting a different degree of aggressive behavior. (In all three, the malignancy resulted from genetic alteration.)

Using PWS, the researchers were able to distinguish each cell line. They found architectural disorder in all three but of varying degrees; the most aggressively malignant cell line showed the most intracellular disorder. When viewed using microscopy, all three cell lines looked normal, and each was indistinguishable from the others. The same trend was found in the researchers' study of cells from an animal model.

"If the PWS screening technique for colon cancer is validated by appropriate clinical trials, there is the potential for preventing many thousands of cancer deaths each year," said Allen Taflove, professor of electrical engineering and computer science at Northwestern. He collaborated with Backman in conducting computer simulations of how light interacts with the complex structure of a cell and is an author of the paper.

In addition to cancer research, PWS could find use in biomechanics (to study the nanoscale architecture of polymers, materials or tissue), tissue engineering and stem cell research.

"Anywhere you use microscopy you could use PWS and get more information," said Backman. "PWS can work with virtually anything, and it can detect features as small as 20 nanometers."


'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
Breaking Medicine Technology: